Your account is not claimed yet. You can sign up with ORCID to claim your account.

Zhi-Ming Li (Zhiming Li)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 22

Top Venues

Cancer medicine

Biomarkers in medicine

Cell death & disease

American journal of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Xiaoqing Sun, Jianghua Cao, Peng Sun, Hang Yang, Huan Li, Wenjuan Ma, Xianqiu Wu, Xiaohua He, Jing Li, Zhi-Ming Li, Jiajia Huang
Pretreatment soluble Siglec-5 protein predicts early progression and R-CHOP efficacy in diffuse large B-cell lymphoma. Biomarkers in medicine 17 (3) (2023)
Tianxiao Gao, Jieye Huang, Haofan Yin, Jiajia Huang, Jinye Xie, Ti Zhou, Wei Fan, Xia Yang, Guoquan Gao, Zhi-Ming Li
Inhibition of extranodal NK/T-cell lymphoma by Chiauranib through an AIF-dependent pathway and its synergy with L-asparaginase. Cell death & disease 14 (5) (2023)
Tianxiao Gao, Jieye Huang, Haofan Yin, Jiajia Huang, Jinye Xie, Ti Zhou, Wei Fan, Xia Yang, Guoquan Gao, Zhi-Ming Li
Inhibition of extranodal NK/T-cell lymphoma by Chiauranib through an AIF-dependent pathway and its synergy with L-asparaginase. Cell death & disease 14 (5) (2023)
Zhiming Li, Hang Yang, Baitian Zhao, Yu Wang, Man Nie, Kangming Huang, Zhi-Ming Li
Outcomes of COVID-19 in patients with lymphomas participating in registered clinical trials: A real-world study from China in the Omicron outbreak era. Cancer medicine (2023)
Xiaoqing Sun, Jianghua Cao, Peng Sun, Hang Yang, Huan Li, Wenjuan Ma, Xianqiu Wu, Xiaohua He, Jing Li, Zhi-Ming Li, Jiajia Huang
Pretreatment soluble Siglec-5 protein predicts early progression and R-CHOP efficacy in diffuse large B-cell lymphoma. Biomarkers in medicine 17 (3) (2023)
Tingyu Wang, Xiuhua Sun, Lihua Qiu, Hang Su, Junning Cao, Zhi-Ming Li, Yuqin Song, Li Zhang, Xiaojian Zhu, Huijing Wu, Wei Zhang, Junmin Li, Ke-Shu Zhou, Hui Zhou, Yu Yang, Zhifeng Li, Hong Cen, Zhen Cai, Zhihui Zhang, Weijun Fu, Jie Jin, Fei Li, Weixin Wu, Xuekui Gu, Weiliang Zhu, Lihong Liu, Zhenjiang Li, Shuhua Yi, Hanying Bao, Zusheng Xu, Lugui Qiu
The oral PI3Kδ inhibitor linperlisib for the treatment of relapsed and/or refractory follicular lymphoma: A phase 2, single-arm, open-label clinical trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Xiaoqing Sun, Jianghua Cao, Peng Sun, Hang Yang, Huan Li, Wenjuan Ma, Xianqiu Wu, Xiaohua He, Jing Li, Zhi-Ming Li, Jiajia Huang
Pretreatment soluble Siglec-5 protein predicts early progression and R-CHOP efficacy in diffuse large B-cell lymphoma. Biomarkers in medicine 17 (3) (2023)
Tianxiao Gao, Jieye Huang, Haofan Yin, Jiajia Huang, Jinye Xie, Ti Zhou, Wei Fan, Xia Yang, Guoquan Gao, Zhi-Ming Li
Inhibition of extranodal NK/T-cell lymphoma by Chiauranib through an AIF-dependent pathway and its synergy with L-asparaginase. Cell death & disease 14 (5) (2023)
Xiaoqing Sun, Jianghua Cao, Peng Sun, Hang Yang, Huan Li, Wenjuan Ma, Xianqiu Wu, Xiaohua He, Jing Li, Zhi-Ming Li, Jiajia Huang
Pretreatment soluble Siglec-5 protein predicts early progression and R-CHOP efficacy in diffuse large B-cell lymphoma. Biomarkers in medicine 17 (3) (2023)
Lijuan Deng, Zhi-Ming Li, Huilai Zhang, Haiwen Huang, Jian-da Hu, Lihong Liu, Ting Liu, Jie Jin, Zunmin Zhu, Wenyu Li, Zhenqian Huang, Wenrong Huang, Ke-Shu Zhou, Haiyan Yang, Mingzhi Zhang, Kaiyang Ding, Hui Zhou, Han Yan, Yuerong Shuang, Junning Cao, Sujun Gao, Dengju Li, Zimin Sun, Qingyuan Zhang, Shuhua Yi, Chun-Yan Ji, Liansheng Zhang, Cheng Hou, Yue Du, Weige Wang, Renbin Zhao, Yuqin Song, Jun Zhu
Orelabrutinib for the treatment of relapsed or refractory marginal zone lymphoma: A phase 2, multicenter, open-label study. American journal of hematology (2023)
Zhiming Li, Yajun Li, Cong Li, Kexing Ren, Yu Wang, Hang Yang, Wenqi Jiang, Liqun Zou, Haiyan Yang, Hui Zhou, Zhi-Ming Li
A Phase II Study of Sintilimab, Anlotinib, and Pegaspargase Sandwiched with Radiotherapy as First-line Therapy in Patients with Newly Diagnosed, Stage I-II Extranodal Natural-killer/T-cell Lymphoma. American journal of hematology (2023)
Tianxiao Gao, Jieye Huang, Haofan Yin, Jiajia Huang, Jinye Xie, Ti Zhou, Wei Fan, Xia Yang, Guoquan Gao, Zhi-Ming Li
Inhibition of extranodal NK/T-cell lymphoma by Chiauranib through an AIF-dependent pathway and its synergy with L-asparaginase. Cell death & disease 14 (5) (2023)
Xiaoqing Sun, Jianghua Cao, Peng Sun, Hang Yang, Huan Li, Wenjuan Ma, Xianqiu Wu, Xiaohua He, Jing Li, Zhi-Ming Li, Jiajia Huang
Pretreatment soluble Siglec-5 protein predicts early progression and R-CHOP efficacy in diffuse large B-cell lymphoma. Biomarkers in medicine (2023)
Yuchen Zhang, Pan-Pan Liu, Jun Cai, Hongmei Jing, Liqun Zou, Huiqiang Huang, Yuanbin Wu, Wenyu Li, Liye Zhong, Xueli Jin, Xu Ye, Ru Feng, Huilai Zhang, Liling Zhang, Lie Lin, Xiuhua Sun, Yuyang Tian, Zhongjun Xia, Zhi-Ming Li, He Huang, Yi Xia, Qing-Qing Cai
Ibrutinib as monotherapy versus combination therapy in Chinese patients with relapsed/refractory mantle cell lymphoma: A multicenter study. Cancer medicine 11 (22) (2022)
Chong Wei, Wei Li, Liping Qin, Shan Liu, Chang Xue, Kexing Ren, Zirong Zhang, Caili Liu, Fang Bao, Huilai Zhang, Hui Zhou, Zhi-Ming Li, Huijing Wu, Liqun Zou, Lihong Liu, Hongmei Jing, Wei Zhang
Clinicopathologic characteristics, outcomes, and prognostic factors of angioimmunoblastic T-cell lymphoma in China. Cancer medicine (2022)
Xiaohua He, Yinglu Xiao, Shan Liu, Ruyan Deng, Zhi-Ming Li, Xianying Zhu
Predicting the Immune Microenvironment and Prognosis with a NETosis-Related lncRNA Signature in Head and Neck Squamous Cell Carcinoma. BioMed research international 2022 (2022)
Hai-Xia He, Yan Gao, Bing Bai, Xiao-Xiao Wang, Ji-Bin Li, Cheng Huang, Jia-Ying Mao, Li-Qin Ping, Qi-Xiang Rong, Yan-Xia He, He Huang, Qing-Qing Cai, Zhi-Ming Li, Wen-Qi Jiang, Hui-Qiang Huang
The beneficial effect of Escalated-R-CHOP-21 for the treatment of diffuse large B-cell lymphoma in elderly male patients: A propensity-matched cohort study. Cancer medicine 10 (21) (2021)
Xiaoqing Sun, Caiqin Wang, Cui Chen, Jiajia Huang, Xianqiu Wu, Yu Wang, Xiaohua He, Jianghua Cao, Wenqi Jiang, Peng Sun, Zhi-Ming Li
Combined tumor-associated macrophages biomarker predicting extremely poor outcome of patients with primary central nervous system lymphoma. Hematological oncology 39 (5) (2021)
Caiqin Wang, Yu Wang, Jianghua Cao, Xiaoqing Sun, Xiaohua He, Peng Sun, Tianxiao Gao, Jiajia Huang, Zhi-Ming Li
Elevated expression of HMGB1 is prognostic of poor survival in patients with relapsed/refractory T/NK-CL. Annals of hematology 100 (9) (2021)
Pei-Dong Chi, Yi-Jun Liu, Yu-Hua Huang, Ming-Jie Mao, Yu Wang, Zhi-Ming Li, Jian Li
Rinsing sampling of core needle biopsy for flow cytometric analysis: A favorable method for lymphoma diagnosis. Cancer medicine 9 (24) (2020)
Ke Wu, Xiao-Qing Sun, Cai-Qin Wang, Tian-Xiao Gao, Peng Sun, Yu Wang, Wen-Qi Jiang, Zhi-Ming Li, Jia-Jia Huang
Metronomic combination chemotherapy using everolimus and etoposide for the treatment of non-Hodgkin lymphoma. Cancer medicine 8 (10) (2019)
Pan-Pan Liu, Yi Xia, Xi-Wen Bi, Yu Wang, Peng Sun, Hang Yang, Zhi-Ming Li, Wen-Qi Jiang
Trends in Survival of Patients with Primary Gastric Diffuse Large B-Cell Lymphoma: An Analysis of 7051 Cases in the SEER Database. Disease markers 2018 (2018)

Zhi-Ming Li.css-eqlu8i{font-size:small;padding-left:4px;} (Zhiming Li)

Publication Activity (10 Years)

Top Topics

Top Venues

Zhi-Ming Li (Zhiming Li)